<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Medical academic journal</journal-id><journal-title-group><journal-title xml:lang="en">Medical academic journal</journal-title><trans-title-group xml:lang="ru"><trans-title>Медицинский академический журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1608-4101</issn><issn publication-format="electronic">2687-1378</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">58500</article-id><article-id pub-id-type="doi">10.17816/MAJ58500</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original study articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные исследования</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">The role of cytomegalovirus and interleukin-8 in destabilization of atherosclerotic lesions in humans</article-title><trans-title-group xml:lang="ru"><trans-title>Роль цитомегаловируса и интерлейкина-8 в дестабилизации атеросклеротических поражений у человека</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="scopus">6602920398</contrib-id><contrib-id contrib-id-type="spin">8367-9096</contrib-id><name-alternatives><name xml:lang="en"><surname>Maltseva</surname><given-names>Svetlana V.</given-names></name><name xml:lang="ru"><surname>Мальцева</surname><given-names>Светлана Владимировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD (Biology), Researcher Associate, Department of General Morphology</p></bio><bio xml:lang="ru"><p>канд. биол­. наук, старший научный сотрудник отдела общей и частной морфологии</p></bio><email>moon25@rambler.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5906-6771</contrib-id><contrib-id contrib-id-type="spin">8636-4271</contrib-id><name-alternatives><name xml:lang="en"><surname>Pigarevsky</surname><given-names>Peter V.</given-names></name><name xml:lang="ru"><surname>Пигаревский</surname><given-names>Петр Валерьевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, DSc (Biology), Head of the Department of General Morphology</p></bio><bio xml:lang="ru"><p>д-р биол. наук, заведующий отделом общей и частной морфологии</p></bio><email>pigarevsky@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="spin">4761-3575</contrib-id><name-alternatives><name xml:lang="en"><surname>Davydova</surname><given-names>Natalya G.</given-names></name><name xml:lang="ru"><surname>Давыдова</surname><given-names>Наталья Геннадьевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD (Medicine), Researcher Associate, Department of General Morphology</p></bio><bio xml:lang="ru"><p>канд. мед. наук, старший научный сотрудник отдела общей и частной морфологии</p></bio><email>tatashaspb@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9925-2886</contrib-id><contrib-id contrib-id-type="spin">8088-4446</contrib-id><name-alternatives><name xml:lang="en"><surname>Snegova</surname><given-names>Vlada A.</given-names></name><name xml:lang="ru"><surname>Снегова</surname><given-names>Влада Андреевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Researcher Associate, Department of General Morphology</p></bio><bio xml:lang="ru"><p>научный сотрудник отдела общей и частной морфологии</p></bio><email>biolaber@inbox.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Institute of Experimental Medicine</institution></aff><aff><institution xml:lang="ru">Федеральное государственное бюджетное научное учреждение «Институт экспериментальной медицины»</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2021-01-27" publication-format="electronic"><day>27</day><month>01</month><year>2021</year></pub-date><pub-date date-type="pub" iso-8601-date="2021-06-10" publication-format="electronic"><day>10</day><month>06</month><year>2021</year></pub-date><volume>21</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>11</fpage><lpage>17</lpage><history><date date-type="received" iso-8601-date="2021-01-18"><day>18</day><month>01</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-01-27"><day>27</day><month>01</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2021, Maltseva S.V., Pigarevsky P.V., Davydova N.G., Snegova V.A.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2021, Мальцева С.В., Пигаревский П.В., Давыдова Н.Г., Снегова В.А.</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="en">Maltseva S.V., Pigarevsky P.V., Davydova N.G., Snegova V.A.</copyright-holder><copyright-holder xml:lang="ru">Мальцева С.В., Пигаревский П.В., Давыдова Н.Г., Снегова В.А.</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-nd/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.eco-vector.com/MAJ/article/view/58500">https://journals.eco-vector.com/MAJ/article/view/58500</self-uri><abstract xml:lang="en"><p><bold><italic>Relevance.</italic></bold> Currently, the role of persistent infections in the atherogenesis development mechanism is not fully understood. Therefore, it’s important to analyze the role of viral infection against the background of the pro-inflammatory cytokines expression in atherosclerotic plaque destabilization.</p> <p><bold><italic>The aim</italic></bold> of the work was a comparative immunohistochemical study of cytomegalovirus (CMV) and IL-8 in different types of human atherosclerotic lesions during their destabilization.</p> <p><bold><italic>Materials and methods.</italic></bold> The study was carried out on 130 autopsy samples of human aorta. CMV was detected by direct immunofluorescent antibody staining. IL-8 was detected by two-stage streptavidin-biotin antibody staining.</p> <p><bold><italic>Results.</italic></bold> It has been shown that active detection of both CMV and IL-8 is characteristic of atherogenesis foci of the arterial intima with the most intense immune-inflammatory changes. The obtained results indicate the synergism of the cellular response to CMV and IL-8 in the vascular wall during the destabilization atherosclerotic lesions process.</p> <p><bold><italic>Conclusion.</italic></bold> According to the results of the work, it can be concluded that both the presence of CMV in atherosclerotic lesions and the high production of IL-8 play a significant role in the formation of unstable atherosclerotic plaques in the vascular wall.</p></abstract><trans-abstract xml:lang="ru"><p><bold><italic>Актуальность.</italic></bold> В настоящее время роль персистирующих инфекций в механизме развития атерогенеза недостаточно изучена, поэтому анализ участия агентов вирусной природы на фоне экспрессии провоспалительных цитокинов при дестабилизации атеросклеротических поражений является актуальным.</p> <p><bold><italic>Цель</italic></bold> работы состояла в сравнительном иммуногистохимическом исследовании выявления цитомегаловируса и интерлейкина-8 в различных типах атеросклеротических поражений у человека на фоне их дестабилизации.</p> <p><bold><italic>Материалы и методы.</italic></bold> Исследование выполнено на аутопсийном материале — 130 образцов ткани аорты человека — с использованием прямого иммунофлюоресцентного метода выявления цитомегаловируса и двухступенчатого стрептавидин-биотинового окрашивания с антителами к интерлейкину-8.</p> <p><bold><italic>Результаты.</italic></bold> Активное выявление цитомегаловируса характерно для очагов атерогенеза с наиболее выраженными иммуновоспалительными изменениями в интиме артерий наряду с активной продукцией интерлейкина-8 в тех же локализациях. Полученные результаты свидетельствуют о синергизме клеточного ответа на цитомегаловирус и интерлейкин-8 в сосудистой стенке в процессе дестабилизации атеросклеротических поражений.</p> <p><bold><italic>Заключение.</italic></bold> Присутствие цитомегаловируса в атеросклеротических бляшках и активная продукция интерлейкина-8 играют существенную роль в формировании нестабильных атеросклеротических поражений в сосудистой стенке.</p></trans-abstract><kwd-group xml:lang="en"><kwd>atherosclerosis</kwd><kwd>cytomegalovirus</kwd><kwd>interleukin-8</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>атеросклероз</kwd><kwd>цитомегаловирус</kwd><kwd>интерлейкин-8</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Nagornev VA, Maltseva SV. The role of infection in the development of immune inflammation and pathogenesis of atherosclerosis. Pathology Archive. 2000;62(6):55–59. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Нагорнев В.А., Мальцева С.В. Роль инфекции в развитии иммунного воспаления и патогенезе атеросклероза // Архив патологии. 2000. Т. 62, № 6. С. 55–59.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Nagornev VA. Pathogenesis of atherosclerosis. Saint Petersburg: Khromis; 2006. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Нагорнев В.А. Патогенез атеросклероза. СПб.: Хромис, 2006.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Fabricant CG, Fabricant J, Minick CR, Litrenta MM. Herpesvirus-induced atherosclerosis in chickens. Fed Proc. 1983;42(8):2476–2479.</mixed-citation><mixed-citation xml:lang="ru">Fabricant C.G., Fabricant J., Minick C.R., Litrenta M.M. Herpesvirus-induced atherosclerosis in chickens // Fed. Proc. 1983. Vol. 42, No. 8. P. 2476–2479.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Du Y, Zhang G, Liu Z. Human cytomegalovirus infection and coronary heart disease: a systematic review. Virol J. 2018;15(1):31. DOI: 10.1186/s12985-018-0937-3</mixed-citation><mixed-citation xml:lang="ru">Du Y., Zhang G., Liu Z. Human cytomegalovirus infection and coronary heart disease: a systematic review // Virol. J. 2018. Vol. 15, No. 1. P. 31. DOI: 10.1186/s12985-018-0937-3</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Adam E, Melnick JL, DeBakey ME. Cytomegalovirus infection and atherosclerosis. Cent Eur J Public Health. 1997;5(3):99–106.</mixed-citation><mixed-citation xml:lang="ru">Adam E., Melnick J.L., DeBakey M.E. Cytomegalovirus infection and atherosclerosis // Cent. Eur. J. Public Health. 1997. Vol. 5, No. 3. P. 99–106.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Melnick JL, Hu C, Burek J, et al. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J Med Virol. 1994;42(2):170–174. DOI: 10.1002/jmv.1890420213</mixed-citation><mixed-citation xml:lang="ru">Melnick J.L., Hu C., Burek J. et al. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis // J. Med. Virol. 1994. Vol. 42, No. 2. P. 170–174. DOI: 10.1002/jmv.1890420213</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Li HZ, Wang Q, Zhang YY, et al. Onset of coronary heart disease is associated with HCMV infection and increased CD14+CD16+ monocytes in a mopulation of weifang, China. Biomed Environ Sci. 2020;33(8):573–582. DOI: 10.3967/bes2020.076</mixed-citation><mixed-citation xml:lang="ru">Li H.Z., Wang Q., Zhang Y.Y. et al. Onset of coronary heart disease is associated with HCMV infection and increased CD14+CD16+ monocytes in a mopulation of weifang, China // Biomed Environ. Sci. 2020. Vol. 33, No. 8. P. 573–582. DOI: 10.3967/bes2020.076</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Lebedeva AM, Shpektor AV, Vasilieva EYu, Margolis LB. Cytomegalovirus infection in cardiovascular diseases. Biochemistry (Mosc). 2018;83(12):1437–1447. DOI: 10.1134/S0006297918120027</mixed-citation><mixed-citation xml:lang="ru">Лебедева А.М., Шпектор А.В., Васильева Е.Ю., Марголис Л.Б. Цитомегаловирусная инфекция при сердечно-сосудистых заболеваниях // Биохимия. 2018. Т. 83, № 12. С. 1767–1778. DOI: 10.1134/S0320972518120023</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Niyi-Odumosu FA, Bello OA, Biliaminu SA, et al. Resting serum concentration of high-sensitivity C-reactive protein (hs-CRP) in sportsmen and untrained male adults. Niger J Physiol Sci. 2017;31(2):177–81.</mixed-citation><mixed-citation xml:lang="ru">Niyi-Odumosu F.A., Bello O.A., Biliaminu S.A. et al. Resting serum concentration of high-sensitivity C-reactive protein (hs-CRP) in sportsmen and untrained male adults // Niger J. Physiol. Sci. 2017. Vol. 31, No. 2. P. 177–81.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Pigarevsky PV, Maltseva SV, Snegova VA. Progressive atherosclerotic lesions in humans. Morphological and immuno-inflammatory aspects. Cytokines and inflammation. 2013;12(1–2):5–12. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Пигаревский П.В., Мальцева С.В., Снегова В.А. Прогрессирующие атеросклеротические поражения у человека. Морфологические и иммуновоспалительные аспекты // Цитокины и воспаление. 2013. Т. 12, № 1–2. С. 5–12.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Ragino JuI, Chernjavskij AM, Polonskaja JaV, et al. Contents of proinflammatory cytokines, chemoattractants and destructive metalloproteinases in various tipes of unstable atherosclerotic plaques. The Journal of Atherosclerosis and Dyslipidemias. 2011;(1):23–27. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Рагино Ю.И., Чернявский А.М., Полонская Я.В. и др. Содержание провоспалительных цитокинов, хемоаттрактантов и деструктивных металлопротеиназ в разных типах нестабильных атеросклеротических бляшек // Атеросклероз и дислипидемии. 2011. № 1. С. 23–27.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Nagornev VA, Anestiady VH, Zota E. Pathomorphosis of atherosclerosis (immunoaspects). Saint Petersburg; Kishinev; 2008. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Нагорнев В.А., Анестиади В.Х., Зота Е. Патоморфоз атеросклероза (иммуноаспекты). СПб.: Кишинев, 2008.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Pigarevsky PV, Maltseva SV, Snegova VA, et al. The role of Interleukin-8 and T-lymphocytes in atherosclerotic plaque destabilization in human. Medical Academic Journal. 2016;16(2):51–55. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Пигаревский П.В., Мальцева С.В., Снегова В.А. и др. Роль интерлейкина-8 и Т-лимфоцитов в дестабилизации атеросклеротической бляшки у человека // Медицинский академический журнал. 2016. Т. 16, № 2. С. 51–55.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Cheng X, Yu X, Ding Y-J, et al. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol. 2008;127(1):89–97. DOI: 10.1016/j.clim.2008.01.009</mixed-citation><mixed-citation xml:lang="ru">Cheng X., Yu X., Ding Y.-J. et al. The Th17/Treg imbalance in patients with acute coronary syndrome // Clin. Immunol. 2008. Vol. 127, No. 1. P. 89–97. DOI: 10.1016/j.clim.2008.01.009</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Romuk E, Skrzep-Poloczek B, Wojciechowska C. Selectin-P and interleukin-8 plasma levels in coronary heart disease patients. Eur J Clin Invest. 2002;32(9):657–661. DOI: 10.1046/j.1365-2362.2002.01053.x</mixed-citation><mixed-citation xml:lang="ru">Romuk E., Skrzep-Poloczek B., Wojciechowska C. Selectin-P and interleukin-8 plasma levels in coronary heart disease patients // Eur. J. Clin. Invest. 2002. Vol. 32, No. 9. P. 657–661. DOI: 10.1046/j.1365-2362.2002.01053.x</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Velasquez IM, Frumento P, Johansson K, et al. Association of interleukin 8 with myocardial infarction: results from the Stockholm Heart Epidemiology Program. Int J Cardiol. 2014;172(1):173–178. DOI: 10.1016/j.ijcard.2013.12.170</mixed-citation><mixed-citation xml:lang="ru">Velasquez I.M., Frumento P., Johansson K. et al. Association of interleukin 8 with myocardial infarction: results from the Stockholm Heart Epidemiology Program // Int. J. Cardiol. 2014. Vol. 172, No. 1. P. 173–178. DOI: 10.1016/j.ijcard.2013.12.170</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">Popovic M, Smiljanic K, Dobutovic B, et al. Human cytomegalovirus infection and atherothrombosis. Thrombolysis. 2012;(33):160–72.</mixed-citation><mixed-citation xml:lang="ru">Popovic M., Smiljanic K., Dobutovic B. et al. Human cytomegalovirus infection and atherothrombosis // Thrombolysis. 2012. No. 33. P. 160–72.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">Mocarski ES, Stinski M. Persistence of the cytomegalovirus genome in human cells. J Virol. 1979;31(3):761–775. DOI: 10.1128/JVI.31.3.761-775.1979</mixed-citation><mixed-citation xml:lang="ru">Mocarski E.S., Stinski M. Persistence of the cytomegalovirus genome in human cells // J. Virol. 1979. Vol. 31, No. 3. P. 761–775. DOI: 10.1128/JVI.31.3.761-775.1979</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">Lebedeva AM, Albakova RM, Albakova TM. Cytomegalovirus infection and atherosclerosis. Infectious Diseases: News. Opinions. Training. 2017;6(23):72–78. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Лебедева А.М., Албакова Р.М., Албакова Т.М. Цитомегаловирусная инфекция и атеросклероз // Инфекционные болезни: Новости. Мнения. Обучение. 2017. № 6(23). С. 72–78.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
